Analysis published in New England Journal of Medicine highlights discovery of new predictive biomarkers for Vectibix® (panitumumab)
Study links RAS mutations to Vectibix clinical response in patients…
11 September 2013 | By Amgen
Study links RAS mutations to Vectibix clinical response in patients with metastatic colorectal cancer...